Patrick, Hayes H. http://orcid.org/0000-0002-2635-4435
Sherman, Jonathan H.
Elder, J. Bradley
Olson, Jeffrey J.
Article History
Received: 8 September 2021
Accepted: 18 October 2021
First Online: 4 March 2022
Declarations
:
: All Guideline Task Force members were required to disclose all potential COIs prior to beginning work on the guideline, using the COI disclosure form of the AANS/CNS Joint Guidelines Review Committee. The CNS Guidelines Committee and Guideline Task Force Chair reviewed the disclosures and either approved or disapproved the nomination and participation on the task force. The CNS Guidelines Committee and Guideline Task Force Chair may approve nominations of task force members with possible conflicts and restrict the writing, reviewing, and/or voting privileges of that person to topics that are unrelated to the possible COIs. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this series of articles.
: These guidelines were funded exclusively by the Congress of Neurological Surgeons (CNS) and the Joint Section on Tumors, which received no funding from outside commercial sources to support the development of this document.
: All authors involved in this review have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this series of articles. The authors declare that they have no conflict of interest.
: Informed consent was not necessary for obtaining data for this review.
: This article does not contain any studies with human participants or animals performed by any of the authors.